Health spending watchdog rules Alzheimer’s drug should not be rolled out on NHS | ITV News

A new drug which has been shown to slow the progression of Alzheimer’s disease should not be rolled out on the NHS, the health service spending watchdog has recommended.

The National Institute for Health and Care Excellence (Nice) said the benefits of lecanemab are "just too small to justify the significant cost to the NHS".

• Subscribe to ITV News on YouTube: http://bit.ly/2lOHmNj
• Get breaking news and more stories at http://www.itv.com/news

Follow ITV News on Facebook: https://www.facebook.com/itvnews/
Follow ITV News on Twitter: https://twitter.com/itvnews
Follow ITV News on Instagram: https://www.instagram.com/itvnews/